Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumour

Florian Grimpen; Desmond Yip; Grant McArthur; Paul Waring; David Goldstein; Maurice Loughrey; Victoria Beshay; Guan Chong

doi:10.1016/S1470-2045(05)70321-1

Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumour

Florian Grimpen, Desmond Yip^*, Grant McArthur, Paul Waring, David Goldstein, Maurice Loughrey, Victoria Beshay, Guan Chong

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

37 Citations (Scopus)

Original language	English
Pages (from-to)	724-727
Number of pages	4
Journal	The Lancet Oncology
Volume	6
Issue number	9
DOIs	https://doi.org/10.1016/S1470-2045(05)70321-1
Publication status	Published - Sept 2005
Externally published	Yes

Access to Document

10.1016/S1470-2045(05)70321-1

Cite this

@article{f374baa3bf074bfa9f95168a67b789fe,

title = "Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumour",

author = "Florian Grimpen and Desmond Yip and Grant McArthur and Paul Waring and David Goldstein and Maurice Loughrey and Victoria Beshay and Guan Chong",

year = "2005",

month = sep,

doi = "10.1016/S1470-2045(05)70321-1",

language = "English",

volume = "6",

pages = "724--727",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "9",

}

TY - JOUR

T1 - Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumour

AU - Grimpen, Florian

AU - Yip, Desmond

AU - McArthur, Grant

AU - Waring, Paul

AU - Goldstein, David

AU - Loughrey, Maurice

AU - Beshay, Victoria

AU - Chong, Guan

PY - 2005/9

Y1 - 2005/9

UR - https://www.scopus.com/pages/publications/24044434901

U2 - 10.1016/S1470-2045(05)70321-1

DO - 10.1016/S1470-2045(05)70321-1

M3 - Article

SN - 1470-2045

VL - 6

SP - 724

EP - 727

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 9

ER -

Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumour

Access to Document

Other files and links

Cite this